4DMedical

4DMedical is a global medical technology company based in Carlton, Australia, with additional offices in Melbourne and Los Angeles. Founded in 2012, the company specializes in four-dimensional lung imaging technology, known as XV Technology™, which is FDA-cleared. Their mission is to improve outcomes for patients with lung diseases by providing detailed insights into lung function and structure throughout the complete breath cycle. The company offers several core products, including the XV LVAS® (Lung Ventilation Analysis Software), which quantitatively measures regional lung function, and the XV Scanner™, the first dedicated lung function scanner that provides rapid, low-dose lung analysis. Additionally, the Permetium Preclinical Scanner is designed for researchers to quantify pulmonary function changes in small animals, supporting drug development and therapeutic research. 4DMedical's technology is utilized by healthcare providers, research institutions, and pharmaceutical companies focused on managing and treating pulmonary diseases. The company is publicly traded on the Australian Securities Exchange under the code 4DX.

• Employees 150
• Founded 2012
• Annual Revenue $3826000
• Total Funding $70500000